Both in Pharmaceuticals
Onconetix vs Alaunos Therapeutics
Over the past year ONCO returned −99.6% and TCRT returned −28.6%; their daily moves had a correlation of -0.02.
ONCO −99.6% TCRT −28.6%Growth of $1, one year, split-adjusted
| Metric | ONCO | TCRT |
|---|---|---|
| Price | $0.6583 | $1.80 |
| Market cap | $3.9M | $4.6M |
| Today | +15.69% | −3.23% |
| 1 month | −0.4% | +142.4% |
| 6 months | −85.4% | −31.6% |
| Year to date | −99.2% | −44.3% |
| 1 year | −99.6% | −33.6% |
| Revenue growth (YoY) | −83.9% | — |
| Gross margin | 25.1% | — |
| Net margin | −16748.3% | — |
| P/E (TTM) | — | — |
| Price / sales | 6.0× | 1,524.3× |
| Net cash | $5.8M | $124.0K |
| Dividend yield | — | — |
| Volatility (60d) | 159.7% | 273.2% |
| Short % of float | 7.4% | 30.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).